DSRV.io · Enforcement-informed quality intelligence
DSRVDSRV.io
Browse by regulation3 articles · 1 high · 2 moderate

21 CFR Part 11

Every DSRV article whose Regulatory Snapshot cites 21 CFR Part 11: the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.

Inspection exposure across the set
In brief
What has FDA cited under 21 CFR Part 11?
3 DSRV articles cite 21 CFR Part 11. Enforcement cases behind them: Anthropic Managed Agents (July 2026 public beta) read against Purolea Cosmetics Lab FDA Warning Letter (April 2026); Production reliability measurements presented by Dynatrace CTO Bernd Greifeneder at Dynatrace Perform 2026, February 2026, on sequential agentic-call degradation and deterministic-first AI architecture; Tetrate governance framework, Securing the MCP Supply Chain, published in the first week of June 2026, alongside MCPManager.ai's regulated-industry MCP compliance guide and the Agentic AI Institute's June 2026 enterprise adoption analysis. Inspection exposure across them: 1 high, 2 moderate.
What does DSRV recommend for 21 CFR Part 11?
From the newest article (Your Next 483 Observation Is Running on a Timer): Defining the QU boundary, validation basis, and change-control wrapper around autonomous agent actions is the firm's job, not the vendor's — settle it before a scheduled agent fires. DSRV is decision support, not legal advice; verify against the official source each article names.
  1. 6 min readHigh exposurecited as a tag

    Your Next 483 Observation Is Running on a Timer

    Anthropic's July 2026 Managed Agents release ships scheduled autonomous runs and authenticated enterprise access. Pharma quality teams that have approved these capabilities without a QU review checkpoint built into the workflow architecture are building toward a Purolea-pattern inspection finding.

    Case
    Anthropic Managed Agents (July 2026 public beta) read against Purolea Cosmetics Lab FDA Warning Letter (April 2026)
    DSRV take
    Defining the QU boundary, validation basis, and change-control wrapper around autonomous agent actions is the firm's job, not the vendor's — settle it before a scheduled agent fires.
  2. 6 min readModerate exposurecited as a tag

    Your Quality Workflows Are Sequential. That Is Where LLMs Fail.

    At Perform 2026, Dynatrace's CTO measured a 95% accurate LLM falling to 60% reliability after 10 sequential agentic calls. Your OOS investigation, CAPA chain, and release decision are exactly that kind of workflow.

    Case
    Production reliability measurements presented by Dynatrace CTO Bernd Greifeneder at Dynatrace Perform 2026, February 2026, on sequential agentic-call degradation and deterministic-first AI architecture.
    DSRV take
    The design decision that determines auditability is sequencing: validated deterministic logic must establish the confirmed facts before any generative layer is asked to reason about them, because better prompts do not change the compounding probability math.
  3. 5 min readModerate exposure

    What Pharma Quality Teams Need to Know About MCP Governance

    Three governance frameworks for MCP-connected AI agents landed in the first week of June 2026. The controls they describe, including audit trails, identity management, sandboxing, and human oversight for high-risk actions, are the same ones 21 CFR Part 11 and EU GMP Annex 11 have required from regulated computer systems for decades. The question is whether your AI agent deployment includes them.

    Case
    Tetrate governance framework, Securing the MCP Supply Chain, published in the first week of June 2026, alongside MCPManager.ai's regulated-industry MCP compliance guide and the Agentic AI Institute's June 2026 enterprise adoption analysis.
    DSRV take
    MCP governance is not a new compliance category; it is Part 11 and Annex 11 applied to a new connection layer, and the validation boundary must cover the agent's tool access before deployment rather than after.
Address this risk

Pressure-test your evidence before an inspector reads it

Bring the document that has to hold up under 21 CFR Part 11. DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.

Apply for the Stability Pilot Ask The Vault about 21 CFR Part 11

Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.